ORION BIOTECH

Build an institutional workflow with ORION.

Tell us what your team covers and how you intend to use ORION. This form is an inquiry, not a checkout, contract, or service-level commitment.

Current pilot scope

  • Source-linked company diligence
  • Curated FDA catalyst review
  • Evidence and limitation review
  • Scoped Watchtower or portfolio evaluation where provisioned

Not generally available

  • No self-serve Fund checkout
  • No published SLA or guaranteed 24/7 monitoring
  • No generally available seats, SSO/SAML, or bulk export
  • No claim of exhaustive global registry coverage

Suggested 6-week evaluation

Agree the coverage set, users, source boundaries, baseline workflow, security checks, measurable success criteria, and expand/extend/stop decision before activation.

Evidence retained

Keep denominators, failed analyses, missed events, source outages, model and method versions, manual interventions, and user feedback. Failed cases are not removed from the evaluation.

Before any purchase

ORION confirms the exact capabilities, data sources, limitations, price, support scope, success criteria, and exit conditions in writing. The inquiry below does not create an entitlement or payment obligation.

← Back to pricing